TR
EN
The effect of hypertension on cognitive dysfunction in female patients with fibromyalgia syndrome
Abstract
Objective
To evaluate the effect of the presence of Hypertension (HT) on cognitive dysfunction in female patients with Fibromyalgia syndrome (FM).
Methods
A total of 36 female patients diagnosed with FM were included in the study and the patients were divided into 4 equal groups. Group 1 was HT with impaired cognition, Group 2 was HT with normal cognition, Group 3 was non-HT with impaired cognition and Group 4 was non-HT with normal cognition. Mini mental status test (MMST) was used to assess cognitive function.
Results
The median age was 51 (41-77) years and median FM complaint duration was 60 (3-336) months. There was no significant difference between the groups in terms of age and complaint duration (p=0.423 and p=0.308, respectively). Median MMST value was 23.5. Between the groups with normal cognition (groups 2 and 4), MMST median value was similar (p=0.203). Median value of MMST was also similar (p=0.192) between the groups with impaired cognition (groups 1 and 3). Also, the median MMST value in patients with HT was similar to in those without HT (p=0.414).
Conclusion
In conclusion, we did not find that HT increases cognitive dysfunction in female FM patients. This may be due to the fact that our number of patients is not large. Additionally, since HT affects cognitive decline more in elderly, new studies can be conducted by including an older FM patient group and a larger number of patients.
Keywords
Ethical Statement
This study was provided from the thesis titled ‘Massachusetts General Hospital cognitive and physical functioning questionnaire Turkish version: A reliability validity study’ numbered ‘770489’. The study protocol was approved by the Ondokuz Mayıs University Clinical Research Ethics Committee (date: 29.04.2021, no: 2021/227).Only the abstract of the study was previously published within the proceedings of Black Sea Rheumatology and Pain Symposium conducted on 24-26 May 2024 (Available at https://www.karat.org.tr/wp-content/uploads/2024/06/KARAT-2024-Tam-Metin-Bildiri-Kitabi.pdf). The study was conducted in accordance with the Declaration of Helsinki and followed the ethical standards of the TÜRKİYE.
References
- Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014;311(15):1547-1555. doi:10.1001/jama.2014.3266
- Bar-On Kalfon T, Gal G, Shorer R, Ablin JN. Cognitive functioning in fibromyalgia: The central role of effort. J Psychosom Res. 2016;87:30-36. doi:10.1016/j.jpsychores.2016.06.004
- Glass JM. Cognitive dysfunction in fibromyalgia syndrome. Journal of Musculoskeletal pain. 2010;18(4):367-372.
- Wolfe F, Clauw DJ, Fitzcharles MA, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46(3):319-329. doi:10.1016/j. semarthrit.2016.08.012
- Kravitz HM, Katz RS. Fibrofog and fibromyalgia: a narrative review and implications for clinical practice. Rheumatol Int. 2015;35(7):1115-1125. doi:10.1007/s00296-014-3208-7
- Katz RS, Heard AR, Mills M, Leavitt F. The prevalence and clinical impact of reported cognitive difficulties (fibrofog) in patients with rheumatic disease with and without fibromyalgia. J Clin Rheumatol. 2004;10(2):53-58. doi:10.1097/01. rhu.0000120895.20623.9f
- Guarner-Lans V, Ramírez-Higuera A, Rubio-Ruiz ME, Castrejón- Téllez V, Soto ME, Pérez-Torres I. Early Programming of Adult Systemic Essential Hypertension. Int J Mol Sci. 2020;21(4):1203. Published 2020 Feb 11. doi:10.3390/ijms21041203
- Lackland DT, Weber MA. Global burden of cardiovascular disease and stroke: hypertension at the core. Can J Cardiol. 2015;31(5):569-571. doi:10.1016/j.cjca.2015.01.009
Details
Primary Language
English
Subjects
Physical Medicine and Rehabilitation
Journal Section
Research Article
Publication Date
February 15, 2025
Submission Date
July 15, 2024
Acceptance Date
November 12, 2024
Published in Issue
Year 2025 Volume: 2 Number: 1
APA
Karaçeşme, M. A., İlhanlı, M., & İlhanlı, İ. (2025). The effect of hypertension on cognitive dysfunction in female patients with fibromyalgia syndrome. Cerasus Journal of Medicine, 2(1), 49-57. https://doi.org/10.70058/cjm.1516432
AMA
1.Karaçeşme MA, İlhanlı M, İlhanlı İ. The effect of hypertension on cognitive dysfunction in female patients with fibromyalgia syndrome. Cerasus J Med. 2025;2(1):49-57. doi:10.70058/cjm.1516432
Chicago
Karaçeşme, Mehmet Alptekin, Manolya İlhanlı, and İlker İlhanlı. 2025. “The Effect of Hypertension on Cognitive Dysfunction in Female Patients With Fibromyalgia Syndrome”. Cerasus Journal of Medicine 2 (1): 49-57. https://doi.org/10.70058/cjm.1516432.
EndNote
Karaçeşme MA, İlhanlı M, İlhanlı İ (February 1, 2025) The effect of hypertension on cognitive dysfunction in female patients with fibromyalgia syndrome. Cerasus Journal of Medicine 2 1 49–57.
IEEE
[1]M. A. Karaçeşme, M. İlhanlı, and İ. İlhanlı, “The effect of hypertension on cognitive dysfunction in female patients with fibromyalgia syndrome”, Cerasus J Med, vol. 2, no. 1, pp. 49–57, Feb. 2025, doi: 10.70058/cjm.1516432.
ISNAD
Karaçeşme, Mehmet Alptekin - İlhanlı, Manolya - İlhanlı, İlker. “The Effect of Hypertension on Cognitive Dysfunction in Female Patients With Fibromyalgia Syndrome”. Cerasus Journal of Medicine 2/1 (February 1, 2025): 49-57. https://doi.org/10.70058/cjm.1516432.
JAMA
1.Karaçeşme MA, İlhanlı M, İlhanlı İ. The effect of hypertension on cognitive dysfunction in female patients with fibromyalgia syndrome. Cerasus J Med. 2025;2:49–57.
MLA
Karaçeşme, Mehmet Alptekin, et al. “The Effect of Hypertension on Cognitive Dysfunction in Female Patients With Fibromyalgia Syndrome”. Cerasus Journal of Medicine, vol. 2, no. 1, Feb. 2025, pp. 49-57, doi:10.70058/cjm.1516432.
Vancouver
1.Mehmet Alptekin Karaçeşme, Manolya İlhanlı, İlker İlhanlı. The effect of hypertension on cognitive dysfunction in female patients with fibromyalgia syndrome. Cerasus J Med. 2025 Feb. 1;2(1):49-57. doi:10.70058/cjm.1516432